PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Wearable devices may prevent astronauts getting 'lost’ in space

Disorientation puts astronauts in danger — now scientists have developed wearable vibrotactile devices to keep them on track

2023-11-03
(Press-News.org) The sky is no longer the limit — but taking flight is dangerous. In leaving the Earth’s surface, we lose many of the cues we need to orient ourselves, and that spatial disorientation can be deadly. Astronauts normally need intensive training to protect against it. But scientists have now found that wearable devices which vibrate to give orientation cues may boost the efficacy of this training significantly, making spaceflight slightly safer.

“Long duration spaceflight will cause many physiological and psychological stressors which will make astronauts very susceptible to spatial disorientation,” said Dr Vivekanand P. Vimal of Brandeis University in the United States, lead author of the article in Frontiers in Physiology. “When disoriented, an astronaut will no longer be able to rely on their own internal sensors which they have depended on for their whole lives.” 

Personal space

The researchers used sensory deprivation and a multi-axis rotation device to test their vibrotactors in simulated spaceflight, so the senses participants would normally rely on were useless. Could the vibrotactors correct the misleading cues the participants would receive from their vestibular systems, and could participants be trained to trust them? 

30 participants were recruited, of which 10 received training to balance in the rotation device, 10 received the vibrotactors, and the remaining 10 received both. All participants were shown a video of the rotation device and told how it worked: moving like an inverted pendulum until it reached a crash boundary, unless it was stabilized by a person sitting in the device controlling it with a joystick. 

Additional training, for the participants who received it, included tasks that taught participants to disengage from their vestibular sense and rely on the vibrotactors instead of their natural gravitational cues. These tasks involved searching for hidden non-upright balance points, which meant participants had to ignore their desire to align to upright and focus on the vibrotactors.

All participants were given a blindfold, earplugs, and white noise to listen to. Those with vibrotactors had four strapped to each arm, which would buzz when they moved away from the balance point. Each participant took part in 40 trials, aiming to keep the rotation device as close to the balance point as possible.

For half the trials, the rotation device operated on a vertical roll plane. This was considered an Earth analog because participants could use their natural gravitational cues for orientation. During the second half, which acted as a spaceflight analog, the rotation device operated on a horizontal roll plane where those gravitational cues could no longer help. 

After each block of trials, participants were asked to rate how disoriented they felt and how much they trusted the vibrotactors. The scientists measured their success by looking at how often they crashed and how well they controlled their balance. 

To infinity and beyond

All the groups were initially disoriented in the spaceflight analog. The scientists expected this, because participants could not rely on the natural gravitational cues that they usually use. Nearly all participants reported that they trusted the vibrotactors, but they also reported confusion from conflicts between their internal cues and the vibrotactors. 

The participants wearing vibrotactors still performed better than those who only received training. The training-only group crashed more frequently, moved around the balance point more, and accidentally destabilized themselves more often. Receiving the training did help, though. As the trials continued, the group who received both training and vibrotactors performed best. 

However, even with training, the participants didn’t perform as well as they did in the Earth analog. They may have needed more time to integrate cues from the vibrotactors, or the buzzing from the vibrotactors may not have given a strong enough danger signal.

“A pilot’s cognitive trust in this external device will most likely not be enough,” said Vimal. “Instead, the trust has to be at a deeper, almost sub-cognitive, level. To achieve this, specialized training will be required.”

If the sensors succeed in more extensive trials, the scientists said, the possible applications for spaceflight are many — from helping astronauts land safely on the surface of a planet, to supporting them as they move outside a vehicle in space. 

END


ELSE PRESS RELEASES FROM THIS DATE:

Involvement of brain peptide dynamics in the pathology of fatty liver disease

Involvement of brain peptide dynamics in the pathology of fatty liver disease
2023-11-03
Niigata, Japan – The research group of Professor Kamimura in Niigata University have demonstrated the complementary role of peripheral and central nervous system on GH–IGF-1axis activation to prevent MASLD progression. IGF-1 ameliorates fatty infiltration in the liver. Its release is controlled by GH and GH activation is managed by peripheral or central nervous system. However, the role of this axis in MASLD developmental phase has not been well identified. Our study demonstrated that the GH–IGF-1 axis is significant in inhibiting the progression of MASLD. In addition to the peripheral autonomic ...

How to measure improvement in Long COVID identified in an international consensus study

2023-11-03
Researchers have reached an agreement on how best to measure the severity and impact of Long COVID by identifying a “Core Outcome Measure Set” (COMS). The research, published in Lancet Respiratory Medicine is co-led by the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London and in collaboration with the World Health Organisation (WHO).   COMS are designed to help researchers and clinicians measure symptoms and impacts of disorders such as Long COVID in the same way, which optimises how data can be compared and summarised. Researchers say this will accelerate the understanding of, and the development ...

Human insulin less temperature-sensitive than previously thought

2023-11-03
A new Cochrane review has found that insulin can be kept at room temperature for months without losing potency, offering hope to people living with diabetes in regions with limited access to healthcare or stable powered refrigeration. This affects millions of people living in low- and middle-income countries, particularly in rural areas, as well as people whose lives have been disrupted by conflict or natural disasters. Human insulin is a hormone produced by the body that helps turn food into energy and controls blood sugar levels. People with diabetes cannot make enough insulin and those with type 1 diabetes have to inject insulin several times a day, typically before every meal. ...

Study reveals untapped potential to increase eye donations needed for sight-restoring surgeries

Study reveals untapped potential to increase eye donations needed for sight-restoring surgeries
2023-11-03
EMBARGOED: Not for Release Until 00:01 AM (UK Time) on Friday 3 November 2023 New research highlights the need for routine discussions about eye donation in end-of-life care clinical settings Less than four per cent of eligible patients in end-of-life care settings were asked to consider eye donation Patients had positive views about eye donation, but most did not know it could be an option for them Staff need training and guidance to support discussing eye donation with patients A new study has found there is significant scope to increase the number of eye donations from patients cared for in hospice and palliative care settings - donations which are desperately needed for ...

Penn Medicine researchers develop gene editing approaches for phenylketonuria treatment

2023-11-02
PHILADELPHIA— Phenylketonuria (PKU) is a rare newborn genetic disease that impacts between 1 in 10,000 to 1 in 20,000 people, depending on the individuals’ genetic ancestry. PKU causes an amino acid—called phenylalanine (Phe)—to build up in the bloodstream. Uncontrolled PKU can lead to intellectual disability, psychiatric issues, and seizures. While current therapies can partially improve outcomes, they require meticulous, lifelong compliance that is very difficult for most patients. ...

Mount Sinai researchers detail mechanism of a key protein implicated in age-related brain dysfunction

Mount Sinai researchers detail mechanism of a key protein implicated in age-related brain dysfunction
2023-11-02
Mount Sinai researchers have shed valuable light on the mechanism of a key protein that regulates the plasticity and function of the hippocampus, a key brain region involved in memory and learning, and that decreases with age in mice. The team’s findings, published in Molecular Psychiatry, could pave the way for a better understanding of how the protein, known as tissue inhibitor of metalloproteinases 2 (TIMP2), could potentially be targeted in age-related disorders like Alzheimer’s disease to help restore ...

UH researcher tackles mysterious Z-RNA structure and its potential connection to diseases

UH researcher tackles mysterious Z-RNA structure and its potential connection to diseases
2023-11-02
University of Houston Assistant Professor of Biology and Biochemistry Quentin Vicens has been awarded a $1.2 million grant from the National Institute of General Medical Sciences to unravel the mystery of Z-RNA – an enigmatic RNA structure within our cells that plays a critical role in immune response. This work is in collaboration with the laboratory of Beat Vögeli, associate professor at the University of Colorado and co-recipient of the award. Vicens, Vögeli and their research teams are on a mission to understand how Z-RNA forms, how often it appears in our genetic material and what it means for ...

Different antibiotics’ effects on gut microbes may impact hypertensive organ damage

2023-11-02
Highlights In a preclinical study, altering the intestinal microbiome with narrow-spectrum antibiotics affected organ damage associated with hypertension. Results from the study will be presented at ASN Kidney Week 2023 November 1–November 5. Philadelphia, PA (November 2, 2023) — New research in rodents indicates that altering gut microbes may affect the development of organ damage associated with hypertension. The findings will be presented at ASN Kidney Week 2023 November 1–November ...

Are sodium-glucose cotransporter-2 inhibitors safe for patients with diabetes and cancer?

2023-11-02
Highlights Investigators found that in patients with diabetes and cancer, sodium glucose cotransporter-2 inhibitors were associated with a higher risk of diabetic ketoacidosis and fracture and a lower risk of acute kidney injury and urinary tract infection compared with glucagon-like peptide 1 receptor agonists. Results from the study will be presented at ASN Kidney Week 2023, November 1–November 5. Philadelphia, PA (November 2, 2023) — Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have heart- and kidney-related benefits for patients with and without diabetes ...

Wildfire air pollution may increase risks of hospitalization and death among patients on dialysis

2023-11-02
Highlights Among individuals receiving in-center hemodialysis treatment in Washington, Oregon, and California, exposure to wildfire-related air pollution was associated with elevated risks of hospitalization and mortality. Results from the study will be presented at ASN Kidney Week 2023 November 1–November 5. Philadelphia, PA (November 2, 2023) — In analyses of data from western US states, increases in wildfire-related air pollution around dialysis clinics were linked to higher rates of hospitalizations and deaths among patients. The research will be presented at ASN Kidney Week 2023 ...

LAST 30 PRESS RELEASES:

Encoding human experience: Study reveals how brain cells compute the flow of time

New study: Deep-sea discovery shines light on life in the twilight zone

Brazilian fossils reveal jaw-dropping discovery in mammal evolution

Now we know why children with Down’s syndrome have higher risk of Leukemia

Emerging SARS-CoV-2 resistance after antiviral treatment

Semaglutide and opioid overdose risk in patients with type 2 diabetes and opioid use disorder

Bronze age lactobacillus genomes clarify kefir history

Higher doses of buprenorphine may improve treatment outcomes for people with opioid use disorder

One in two El Niño events could be extreme by mid-century

Bacterial ‘flipping’ allows genes to assume different forms

Gladstone presents inaugural Sobrato prize in neuroscience to Yadong Huang, a pioneer of Alzheimer’s research

Manganese cathodes could boost lithium-ion batteries

To make fluid flow in one direction down a pipe, it helps to be a shark

Growing divide: Rural men are living shorter, less healthy lives than their urban counterparts

During NY Climate Week, Alex Zhavoronkov PhD, Founder and CEO of Insilico Medicine, talks about Gen AI applications in drug discovery, longevity and climate change solutions at AWS Climate Tech & AI F

First genome-wide comparison of vapers and smokers finds similar DNA changes linked to disease risk

International research challenge to tackle knowledge gaps in women’s cardiovascular health

Pipeline of new drug treatment for non-alcoholic fatty liver disease/metabolic dysfunction-associated steatotic liver disease

Kissick Family Foundation, Milken Institute announce $3 million in funding for frontotemporal dementia research

How does cancer spread? Follow the map

Shrinking AR displays into eyeglasses to expand their use

High academic award for economic geographer Ron Boschma

Study reveals mallards' flight responses ineffective in preventing vehicle collisions

Home- vs office-based narrowband UV-B phototherapy for patients with psoriasis

Major boost in carbon capture and storage essential to reach 2°C climate target

‘Invisible forest’ of algae thrives as ocean warms

How do rare genetic variants affect health? AI provides more accurate predictions

Replacing hype about artificial intelligence with accurate measurements of success

Researchers harness AI to repurpose existing drugs for treatment of rare diseases

Combination treatment improves response to immunotherapy for lung cancer

[Press-News.org] Wearable devices may prevent astronauts getting 'lost’ in space
Disorientation puts astronauts in danger — now scientists have developed wearable vibrotactile devices to keep them on track